22nd Century Group, Inc. is the leading plant biotechnology company accelerating the creation of disruptive new plant lines that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding.